| Primary |
| Peritoneal Dialysis |
61.5% |
| Product Used For Unknown Indication |
23.1% |
| Anticoagulant Therapy |
11.5% |
| Diabetes Mellitus |
3.8% |
|
| Cerebrovascular Accident |
14.3% |
| Death |
14.3% |
| Peritonitis Bacterial |
14.3% |
| Peritoneal Dialysis Complication |
10.7% |
| Sepsis |
7.1% |
| Cardiac Arrest |
3.6% |
| Cardiac Failure |
3.6% |
| Cystitis Noninfective |
3.6% |
| Diarrhoea |
3.6% |
| Haemorrhage |
3.6% |
| Pericarditis Uraemic |
3.6% |
| Peritonitis |
3.6% |
| Respiratory Failure |
3.6% |
| Therapy Cessation |
3.6% |
| Urinary Tract Infection |
3.6% |
| Weight Increased |
3.6% |
|
| Secondary |
| Peritoneal Dialysis |
48.8% |
| Product Used For Unknown Indication |
23.9% |
| Renal Failure Chronic |
7.6% |
| Renal Failure |
2.6% |
| Drug Use For Unknown Indication |
2.5% |
| Hypertension |
2.4% |
| Diabetes Mellitus |
1.5% |
| Diabetic Nephropathy |
1.3% |
| Glomerulonephritis Proliferative |
1.2% |
| Malignant Hypertension |
1.2% |
| Kidney Transplant Rejection |
1.0% |
| Vascular Access Complication |
1.0% |
| Tremor |
0.8% |
| Vitamin Supplementation |
0.8% |
| Wegener's Granulomatosis |
0.8% |
| Iga Nephropathy |
0.6% |
| Prophylaxis |
0.6% |
| Antiinflammatory Therapy |
0.5% |
| Diuretic Therapy |
0.5% |
| Hyperphosphataemia |
0.5% |
|
| Death |
32.8% |
| Peritonitis |
8.3% |
| Sclerosing Encapsulating Peritonitis |
7.7% |
| Sepsis |
5.6% |
| Pyrexia |
5.4% |
| Peritonitis Bacterial |
5.2% |
| Superinfection |
3.7% |
| Acute Myocardial Infarction |
3.5% |
| Infectious Peritonitis |
3.5% |
| Malnutrition |
3.3% |
| Peritoneal Cloudy Effluent |
3.3% |
| Cardiac Arrest |
2.9% |
| Peritoneal Effluent Abnormal |
2.3% |
| Cardiac Failure |
2.1% |
| Weight Decreased |
1.9% |
| Depressed Level Of Consciousness |
1.7% |
| Fluid Overload |
1.7% |
| Fungal Peritonitis |
1.7% |
| Peritonitis Sclerosing |
1.7% |
| Pneumonia |
1.7% |
|
| Concomitant |
| Peritoneal Dialysis |
40.0% |
| Product Used For Unknown Indication |
22.8% |
| Hypertension |
5.6% |
| Immunosuppressant Drug Therapy |
5.6% |
| Renal Failure Chronic |
5.6% |
| Vitamin Supplementation |
2.8% |
| Anaemia |
1.9% |
| Angioplasty |
1.9% |
| Gastrointestinal Motility Disorder |
1.9% |
| Poor Peripheral Circulation |
1.9% |
| Urinary Tract Disorder |
1.9% |
| Acidosis |
0.9% |
| Blood Pressure Management |
0.9% |
| Colitis |
0.9% |
| Depression |
0.9% |
| Hyperlipidaemia |
0.9% |
| Hyperphosphataemia |
0.9% |
| Mineral Supplementation |
0.9% |
| Oedema |
0.9% |
| Off Label Use |
0.9% |
|
| Hypoglycaemia |
10.0% |
| Peritoneal Dialysis Complication |
10.0% |
| Peritonitis |
10.0% |
| Vomiting |
10.0% |
| Musculoskeletal Pain |
7.5% |
| Peritonitis Bacterial |
7.5% |
| Respiratory Arrest |
7.5% |
| Rash |
5.0% |
| Systemic Inflammatory Response Syndrome |
5.0% |
| Bloody Peritoneal Effluent |
2.5% |
| Death |
2.5% |
| Gastroenteritis Viral |
2.5% |
| Grand Mal Convulsion |
2.5% |
| Haemorrhage |
2.5% |
| Kidney Transplant Rejection |
2.5% |
| Malaise |
2.5% |
| Multi-organ Failure |
2.5% |
| Pain |
2.5% |
| Peritoneal Effluent Leukocyte Count Increased |
2.5% |
| Procedural Pain |
2.5% |
|
| Interacting |
| Peritoneal Dialysis |
100.0% |
|
|
